25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

BioSig Technologies, Inc. Common Stock
Buy, Hold or Sell?

Let's analyze Biosig together

I guess you are interested in BioSig Technologies, Inc. Common Stock. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of BioSig Technologies, Inc. Common Stock. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about BioSig Technologies, Inc. Common Stock

I send you an email if I find something interesting about BioSig Technologies, Inc. Common Stock.

1. Quick Overview

1.1. Quick analysis of Biosig (30 sec.)










1.2. What can you expect buying and holding a share of Biosig? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
57.5%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$-0.01
How sure are you?
47.5%

+ What do you gain per year?

Total Gains per Share
$-0.02
Return On Investment
-1.2%

For what price can you sell your share?

Current Price per Share
$1.58
Expected price per share
$0.45 - $2.57
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biosig (5 min.)




Live pricePrice per Share (EOD)
$1.58
Intrinsic Value Per Share
$-9.61 - $11.40
Total Value Per Share
$-9.60 - $11.41

2.2. Growth of Biosig (5 min.)




Is Biosig growing?

Current yearPrevious yearGrowGrow %
How rich?$116k$1.1m-$2.8m-172.4%

How much money is Biosig making?

Current yearPrevious yearGrowGrow %
Making money-$5.1m-$7.9m$2.8m54.5%
Net Profit Margin-146,958.0%-39,137.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Biosig (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biosig?

Welcome investor! Biosig's management wants to use your money to grow the business. In return you get a share of Biosig.

First you should know what it really means to hold a share of Biosig. And how you can make/lose money.

Speculation

The Price per Share of Biosig is $1.58. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosig.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosig, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosig.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.24-15.2%-0.32-20.0%-0.49-31.3%-0.53-33.2%-0.40-25.6%
Usd Book Value Change Per Share0.1811.7%0.00-0.3%-0.10-6.5%-0.03-2.0%0.000.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.2%0.010.6%
Usd Total Gains Per Share0.1811.7%0.00-0.3%-0.10-6.5%-0.03-1.8%0.010.7%
Usd Price Per Share0.35-0.49-0.86-2.75-2.65-
Price to Earnings Ratio-0.36--0.39--0.43--1.27--1.43-
Price-to-Total Gains Ratio1.90-1,343.03--1.97-255.67-129.55-
Price to Book Ratio49.13-8.59-19.62-8.05-3.14-
Price-to-Total Gains Ratio1.90-1,343.03--1.97-255.67-129.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.58
Number of shares632
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.00-0.03
Usd Total Gains Per Share0.00-0.03
Gains per Quarter (632 shares)-3.09-18.00
Gains per Year (632 shares)-12.35-71.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-12-226-78-82
20-25-3412-156-154
30-37-4618-234-226
40-50-5825-313-298
50-62-7031-391-370
60-75-8237-469-442
71-87-9443-547-514
81-99-10649-625-586
91-112-11855-703-658
101-124-13062-781-730

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%1.039.00.02.5%1.042.00.02.3%
Book Value Change Per Share1.02.01.025.0%3.08.01.025.0%6.013.01.030.0%17.022.01.042.5%18.023.02.041.9%
Dividend per Share1.00.03.025.0%8.00.04.066.7%14.00.06.070.0%23.00.017.057.5%23.00.020.053.5%
Total Gains per Share2.02.00.050.0%4.08.00.033.3%7.013.00.035.0%19.021.00.047.5%20.022.01.046.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of BioSig Technologies, Inc. Common Stock compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.184-0.005+103%-0.102+155%-0.031+117%0.001+13334%
Book Value Per Share--0.007-0.101+1524%0.074-90%0.655-99%0.329-98%
Current Ratio--0.8020.325+147%0.731+10%4.361-82%3.311-76%
Debt To Asset Ratio--0.9631.869-48%0.755+27%0.623+55%2.066-53%
Debt To Equity Ratio--30.2127.553+300%5.606+439%2.755+997%1.454+1978%
Dividend Per Share---0.000-100%0.000-100%0.002-100%0.010-100%
Eps---0.241-0.316+31%-0.494+105%-0.525+118%-0.405+68%
Free Cash Flow Per Share---0.091-0.173+90%-0.305+235%-0.324+256%-0.218+140%
Free Cash Flow To Equity Per Share--0.1040.007+1481%-0.059+157%-0.027+126%0.002+4109%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--11.402--------
Intrinsic Value_10Y_min---9.607--------
Intrinsic Value_1Y_max---0.581--------
Intrinsic Value_1Y_min---1.134--------
Intrinsic Value_3Y_max---0.433--------
Intrinsic Value_3Y_min---3.278--------
Intrinsic Value_5Y_max--1.299--------
Intrinsic Value_5Y_min---5.266--------
Market Cap25719714.000+78%5699032.8308039038.455-29%14040033.750-59%44768092.311-87%43128745.414-87%
Net Profit Margin---301.154-1469.580+388%-391.370+30%-520.721+73%-260.360-14%
Operating Margin----1140.9790%-394.2700%-456.7770%-228.3880%
Operating Ratio--408.0771397.415-71%402.770+1%514.087-21%257.043+59%
Pb Ratio221.722+78%49.1308.585+472%19.618+150%8.046+511%3.138+1466%
Pe Ratio-1.642-351%-0.364-0.391+7%-0.433+19%-1.266+248%-1.429+293%
Price Per Share1.580+78%0.3500.494-29%0.863-59%2.750-87%2.649-87%
Price To Free Cash Flow Ratio-4.342-351%-0.962-0.761-21%-0.692-28%-2.081+116%-4.020+318%
Price To Total Gains Ratio8.565+78%1.8981343.034-100%-1.973+204%255.672-99%129.552-99%
Quick Ratio--0.0400.079-49%0.397-90%3.892-99%3.032-99%
Return On Assets---1.260-2.359+87%-1.781+41%-1.133-10%-2.250+79%
Return On Equity---39.545-9.886-75%-13.889-65%-5.135-87%-2.865-93%
Total Gains Per Share--0.184-0.005+103%-0.102+155%-0.028+115%0.011+1555%
Usd Book Value--116000.000-1652000.000+1524%1196750.000-90%10656787.050-99%5353701.425-98%
Usd Book Value Change Per Share--0.184-0.005+103%-0.102+155%-0.031+117%0.001+13334%
Usd Book Value Per Share--0.007-0.101+1524%0.074-90%0.655-99%0.329-98%
Usd Dividend Per Share---0.000-100%0.000-100%0.002-100%0.010-100%
Usd Eps---0.241-0.316+31%-0.494+105%-0.525+118%-0.405+68%
Usd Free Cash Flow---1481000.000-2815250.000+90%-4958500.000+235%-5270043.400+256%-3549443.325+140%
Usd Free Cash Flow Per Share---0.091-0.173+90%-0.305+235%-0.324+256%-0.218+140%
Usd Free Cash Flow To Equity Per Share--0.1040.007+1481%-0.059+157%-0.027+126%0.002+4109%
Usd Market Cap25719714.000+78%5699032.8308039038.455-29%14040033.750-59%44768092.311-87%43128745.414-87%
Usd Price Per Share1.580+78%0.3500.494-29%0.863-59%2.750-87%2.649-87%
Usd Profit---3915000.000-5145500.000+31%-7950250.000+103%-8523783.800+118%-6046470.375+54%
Usd Revenue--13000.0009500.000+37%68750.000-81%38500.000-66%19250.000-32%
Usd Total Gains Per Share--0.184-0.005+103%-0.102+155%-0.028+115%0.011+1555%
 EOD+6 -2MRQTTM+23 -11YOY+18 -165Y+15 -1910Y+15 -19

3.3 Fundamental Score

Let's check the fundamental score of BioSig Technologies, Inc. Common Stock based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.642
Price to Book Ratio (EOD)Between0-1221.722
Net Profit Margin (MRQ)Greater than0-301.154
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.040
Current Ratio (MRQ)Greater than10.802
Debt to Asset Ratio (MRQ)Less than10.963
Debt to Equity Ratio (MRQ)Less than130.212
Return on Equity (MRQ)Greater than0.15-39.545
Return on Assets (MRQ)Greater than0.05-1.260
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of BioSig Technologies, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.728
Ma 20Greater thanMa 501.204
Ma 50Greater thanMa 1000.691
Ma 100Greater thanMa 2000.557
OpenGreater thanClose1.710
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About BioSig Technologies, Inc. Common Stock

BioSig Technologies, Inc., a medical technology company, focuses on deciphering the body's electrical signals starting with heart rhythms. It delivers unprecedented cardiac signal clarity, ending the reliance on mixed signals and reading between the lines. The company's product, the PURE EP Platform, provides real-time signal visualization allowing physicians to perform targeted cardiac ablation procedures with increased procedural efficiency and efficacy. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Fundamental data was last updated by Penke on 2024-11-10 19:26:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biosig earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • A Net Profit Margin of -30,115.4% means that $-301.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is -30,115.4%. The company is making a huge loss. -2
  • The TTM is -146,958.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-30,115.4%TTM-146,958.0%+116,842.6%
TTM-146,958.0%YOY-39,137.0%-107,821.0%
TTM-146,958.0%5Y-52,072.1%-94,886.0%
5Y-52,072.1%10Y-26,036.0%-26,036.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-30,115.4%-5.5%-30,109.9%
TTM-146,958.0%-16.0%-146,942.0%
YOY-39,137.0%-14.9%-39,122.1%
5Y-52,072.1%-18.1%-52,054.0%
10Y-26,036.0%-23.4%-26,012.6%
4.3.1.2. Return on Assets

Shows how efficient Biosig is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • -126.0% Return on Assets means that Biosig generated $-1.26 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is -126.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -235.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-126.0%TTM-235.9%+109.9%
TTM-235.9%YOY-178.1%-57.8%
TTM-235.9%5Y-113.3%-122.6%
5Y-113.3%10Y-225.0%+111.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-126.0%-2.1%-123.9%
TTM-235.9%-3.4%-232.5%
YOY-178.1%-4.0%-174.1%
5Y-113.3%-3.0%-110.3%
10Y-225.0%-4.2%-220.8%
4.3.1.3. Return on Equity

Shows how efficient Biosig is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • -3,954.5% Return on Equity means Biosig generated $-39.55 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is -3,954.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -988.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3,954.5%TTM-988.6%-2,965.9%
TTM-988.6%YOY-1,388.9%+400.3%
TTM-988.6%5Y-513.5%-475.2%
5Y-513.5%10Y-286.5%-227.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3,954.5%-2.1%-3,952.4%
TTM-988.6%-3.8%-984.8%
YOY-1,388.9%-4.2%-1,384.7%
5Y-513.5%-4.4%-509.1%
10Y-286.5%-5.7%-280.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of BioSig Technologies, Inc. Common Stock.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biosig is operating .

  • Measures how much profit Biosig makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-114,097.9%+114,097.9%
TTM-114,097.9%YOY-39,427.0%-74,670.9%
TTM-114,097.9%5Y-45,677.7%-68,420.2%
5Y-45,677.7%10Y-22,838.8%-22,838.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.9%+13.9%
TTM-114,097.9%-17.5%-114,080.4%
YOY-39,427.0%-12.3%-39,414.7%
5Y-45,677.7%-17.6%-45,660.1%
10Y-22,838.8%-19.8%-22,819.0%
4.3.2.2. Operating Ratio

Measures how efficient Biosig is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 408.08 means that the operating costs are $408.08 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 408.077. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1,397.415. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ408.077TTM1,397.415-989.338
TTM1,397.415YOY402.770+994.645
TTM1,397.4155Y514.087+883.328
5Y514.08710Y257.043+257.043
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ408.0771.327+406.750
TTM1,397.4151.347+1,396.068
YOY402.7701.329+401.441
5Y514.0871.371+512.716
10Y257.0431.321+255.722
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of BioSig Technologies, Inc. Common Stock.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biosig is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.80 means the company has $0.80 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 0.802. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.325. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.802TTM0.325+0.477
TTM0.325YOY0.731-0.405
TTM0.3255Y4.361-4.035
5Y4.36110Y3.311+1.050
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8022.573-1.771
TTM0.3252.666-2.341
YOY0.7312.915-2.184
5Y4.3613.393+0.968
10Y3.3113.514-0.203
4.4.3.2. Quick Ratio

Measures if Biosig is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • A Quick Ratio of 0.04 means the company can pay off $0.04 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 0.040. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.079. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.040TTM0.079-0.039
TTM0.079YOY0.397-0.318
TTM0.0795Y3.892-3.813
5Y3.89210Y3.032+0.860
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0401.543-1.503
TTM0.0791.688-1.609
YOY0.3971.900-1.503
5Y3.8922.296+1.596
10Y3.0322.552+0.480
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of BioSig Technologies, Inc. Common Stock.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biosig assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosig to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.96 means that Biosig assets are financed with 96.3% credit (debt) and the remaining percentage (100% - 96.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 0.963. The company is just able to pay all its debts by selling its assets.
  • The TTM is 1.869. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ0.963TTM1.869-0.906
TTM1.869YOY0.755+1.113
TTM1.8695Y0.623+1.246
5Y0.62310Y2.066-1.443
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9630.403+0.560
TTM1.8690.397+1.472
YOY0.7550.358+0.397
5Y0.6230.437+0.186
10Y2.0660.457+1.609
4.5.4.2. Debt to Equity Ratio

Measures if Biosig is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosig to the Medical Devices industry mean.
  • A Debt to Equity ratio of 3,021.2% means that company has $30.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The MRQ is 30.212. The company is unable to pay all its debts with equity. -1
  • The TTM is 7.553. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ30.212TTM7.553+22.659
TTM7.553YOY5.606+1.947
TTM7.5535Y2.755+4.798
5Y2.75510Y1.454+1.301
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ30.2120.552+29.660
TTM7.5530.581+6.972
YOY5.6060.528+5.078
5Y2.7550.630+2.125
10Y1.4540.697+0.757
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biosig generates.

  • Above 15 is considered overpriced but always compare Biosig to the Medical Devices industry mean.
  • A PE ratio of -0.36 means the investor is paying $-0.36 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The EOD is -1.642. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.364. Based on the earnings, the company is expensive. -2
  • The TTM is -0.391. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.642MRQ-0.364-1.278
MRQ-0.364TTM-0.391+0.027
TTM-0.391YOY-0.433+0.042
TTM-0.3915Y-1.266+0.875
5Y-1.26610Y-1.429+0.163
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-1.642-0.937-0.705
MRQ-0.364-1.257+0.893
TTM-0.391-2.000+1.609
YOY-0.433-2.341+1.908
5Y-1.266-2.001+0.735
10Y-1.429-2.046+0.617
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The EOD is -4.342. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.962. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.761. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.342MRQ-0.962-3.380
MRQ-0.962TTM-0.761-0.201
TTM-0.761YOY-0.692-0.069
TTM-0.7615Y-2.081+1.321
5Y-2.08110Y-4.020+1.938
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.342-1.400-2.942
MRQ-0.962-1.683+0.721
TTM-0.761-1.997+1.236
YOY-0.692-5.362+4.670
5Y-2.081-3.585+1.504
10Y-4.020-4.582+0.562
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biosig is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 49.13 means the investor is paying $49.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of BioSig Technologies, Inc. Common Stock:

  • The EOD is 221.722. Based on the equity, the company is expensive. -2
  • The MRQ is 49.130. Based on the equity, the company is expensive. -2
  • The TTM is 8.585. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD221.722MRQ49.130+172.592
MRQ49.130TTM8.585+40.545
TTM8.585YOY19.618-11.033
TTM8.5855Y8.046+0.539
5Y8.04610Y3.138+4.908
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD221.7222.139+219.583
MRQ49.1302.141+46.989
TTM8.5852.324+6.261
YOY19.6183.034+16.584
5Y8.0464.079+3.967
10Y3.1384.526-1.388
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of BioSig Technologies, Inc. Common Stock.

4.8.1. Institutions holding BioSig Technologies, Inc. Common Stock

Institutions are holding 0.01% of the shares of BioSig Technologies, Inc. Common Stock.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31PFG Investments, LLC0.70240.004210614690386573.5152
2024-03-31Vanguard Group Inc0.4552068788687880
2024-03-31BlackRock Inc0.4009060584605840
2024-03-31Geode Capital Management, LLC0.3756056762567620
2024-03-31HRT FINANCIAL LLC0.17430.000126331263310
2024-03-31State Street Corporation0.1174017737177370
2023-12-31Cornerstone Wealth Group, LLC0.01060.00111600000
2024-03-31Commonwealth Equity Services Inc0.0827012500125000
2024-03-31Virtu Financial LLC0.0780.000611782117820
2024-03-31BB&T Corp.0.074301122810.0089
2024-03-31Tower Research Capital LLC0.04660.0001704770470
2024-06-30Webster Bank, N. A.0.02650.0002400040000
2024-03-31Morgan Stanley - Brokerage Accounts0.02110318231820
2024-03-31SIMPLEX TRADING, LLC0.01250188918890
2023-12-31Sugarloaf Wealth Management, LLC0.00070.0001100000
2024-03-31Steward Partners Investment Advisory, LLC0.00609009000
2023-12-31North Star Investment Management Corp0.0005080000
2024-03-31Ronald Blue Trust, Inc.0.002030000
2023-12-31Nelson, Van Denburg & Campbell Wealth Management Group, LLC0.0002030000
2024-03-31Royal Bank of Canada0.001902892890
Total 2.58940.0064407565+362178+88.9%

4.9.2. Funds holding BioSig Technologies, Inc. Common Stock

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-09-30BlackRock Extended Mkt Composite0.03850.00025812500
2024-05-31Fidelity Extended Market Index0.2120.00023203300
2024-05-31Fidelity Series Total Market Index0.05870887400
2024-05-31Fidelity Total Market Index0.05580843000
2024-03-31Northern Trust Extended Eq Market Idx0.03470.0001524900
2023-12-31SSgA U.S. Extended Market Index Class I0.00320.0001480000
2024-05-31Fidelity Nasdaq Composite Index0.02580.0001389500
2023-12-31NT US Market Cap Idx Fd - L0.00240.0001359800
2024-05-31Spartan Total Market Index Pool E0.02120319700
2024-03-31NT Ext Equity Mkt Idx Fd - NL0.01870282700
2024-05-311290 VT Micro Cap K0.00680.0014103400
2024-03-31Douglas C. Lane & Assoc. Core Equity0.003204804800
2024-03-31Northern Trust Wilshire 50000.0024036000
2024-05-31Spartan Extended Market Index Pool E0.0019029000
2024-03-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.00140.0001213122134.0659
2024-05-31Fidelity U.S. Equity Index Ins Trust0.000304300
Total 0.4870.0023133448+602+0.5%

5.3. Insider Transactions

Insiders are holding 30.769% of the shares of BioSig Technologies, Inc. Common Stock.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-06-12Kenneth L LondonerBUY60011.7
2022-09-12John SieckhausBUY5009.1
2022-09-08Kenneth L LondonerBUY22768.4
2022-08-30John SieckhausBUY50010.7
2022-08-29Kenneth L LondonerBUY88510.9
2022-08-25Kenneth L LondonerBUY84511.9
2022-08-24Gray FlemingBUY360311.8
2022-08-24John SieckhausBUY100011.3
2022-08-24Patrick Joseph GallagherBUY170011.6
2022-08-23Kenneth L LondonerBUY120010.9
2022-08-22Steve ChaussyBUY80011.3
2022-08-19Kenneth L LondonerBUY100010
2022-08-16Kenneth L LondonerBUY25109
2022-05-25Kenneth L LondonerBUY93011.5
2022-05-23Kenneth L LondonerBUY118511.4
2022-05-20Kenneth L LondonerBUY36511.3
2021-09-20Kenneth L LondonerBUY26328.1
2021-09-01Kenneth L. LondonerBUY64030.9
2021-08-30Kenneth L LondonerBUY90030.2
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets3,107
Total Liabilities2,991
Total Stockholder Equity99
 As reported
Total Liabilities 2,991
Total Stockholder Equity+ 99
Total Assets = 3,107

Assets

Total Assets3,107
Total Current Assets2,386
Long-term Assets721
Total Current Assets
Cash And Cash Equivalents 2,104
Short-term Investments 65
Net Receivables 54
Total Current Assets  (as reported)2,386
Total Current Assets  (calculated)2,223
+/- 163
Long-term Assets
Property Plant Equipment 398
Intangible Assets 279
Long-term Assets Other 44
Long-term Assets  (as reported)721
Long-term Assets  (calculated)721
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,976
Long-term Liabilities15
Total Stockholder Equity99
Total Current Liabilities
Total Current Liabilities  (as reported)2,976
Total Current Liabilities  (calculated)0
+/- 2,976
Long-term Liabilities
Long-term Liabilities  (as reported)15
Long-term Liabilities  (calculated)0
+/- 15
Total Stockholder Equity
Total Stockholder Equity (as reported)99
Total Stockholder Equity (calculated)0
+/- 99
Other
Capital Stock120
Common Stock Shares Outstanding 15,111
Net Invested Capital -6
Net Working Capital -590
Property Plant and Equipment Gross 2,035



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-30
> Total Assets 
0
0
352
0
105
411
353
2,257
1,391
577
1,031
192
893
335
1,242
1,456
1,100
423
1,700
1,196
4,178
7,748
4,997
11,904
12,062
14,221
14,217
17,841
39,812
34,953
30,386
24,516
18,027
21,673
15,519
12,542
9,590
5,015
4,110
5,197
4,050
3,154
1,798
1,798
3,107
3,1071,7981,7983,1544,0505,1974,1105,0159,59012,54215,51921,67318,02724,51630,38634,95339,81217,84114,21714,22112,06211,9044,9977,7484,1781,1961,7004231,1001,4561,2423358931921,0315771,3912,257353411105035200
   > Total Current Assets 
0
0
302
0
64
370
315
2,219
1,347
536
985
149
847
285
1,190
1,406
1,056
385
1,665
1,154
3,839
7,426
4,629
11,090
10,640
12,883
12,827
16,560
38,652
33,893
29,337
23,334
16,949
19,999
13,894
11,002
7,736
3,089
1,128
2,150
1,987
1,051
528
528
2,386
2,3865285281,0511,9872,1501,1283,0897,73611,00213,89419,99916,94923,33429,33733,89338,65216,56012,82712,88310,64011,0904,6297,4263,8391,1541,6653851,0561,4061,1902858471499855361,3472,21931537064030200
       Cash And Cash Equivalents 
0
0
302
0
42
269
240
2,059
1,197
335
953
138
705
150
1,056
1,244
881
234
1,548
1,035
3,673
7,280
4,450
10,934
10,334
12,309
12,109
15,500
36,927
32,748
28,268
22,475
15,504
17,535
11,659
8,665
5,077
887
357
1,412
1,252
389
190
190
2,104
2,1041901903891,2521,4123578875,0778,66511,65917,53515,50422,47528,26832,74836,92715,50012,10912,30910,33410,9344,4507,2803,6731,0351,5482348811,2441,0561507051389533351,1972,05924026942030200
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
50
101
101
102
102
103
103
65
65103103102102101101500000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
199
100
0
0
0
5
9
17
21
14
24
24
54
5424241421179500010019900000000000000000000000000000000
       Other Current Assets 
0
0
0
0
22
101
76
160
150
201
31
11
142
135
134
162
175
150
117
119
166
146
178
157
306
574
141
261
925
338
301
209
515
483
354
311
633
456
0
376
525
322
0
206
0
020603225253760456633311354483515209301338925261141574306157178146166119117150175162134135142113120115016076101220000
   > Long-term Assets 
0
0
50
0
41
41
38
38
44
42
46
43
46
50
52
50
44
38
36
42
339
322
368
814
1,422
1,339
1,390
1,280
1,160
1,061
1,049
1,183
1,078
1,674
1,625
1,540
1,854
1,926
2,982
3,047
2,063
2,103
1,270
1,270
721
7211,2701,2702,1032,0633,0472,9821,9261,8541,5401,6251,6741,0781,1831,0491,0611,1601,2801,3901,3391,4228143683223394236384450525046434642443838414105000
       Property Plant Equipment 
0
0
25
0
16
16
13
13
17
14
18
16
19
23
24
23
17
19
19
19
21
32
44
434
892
834
895
799
688
598
595
738
640
1,250
1,256
1,175
1,494
1,570
1,490
1,358
1,251
1,123
938
938
398
3989389381,1231,2511,3581,4901,5701,4941,1751,2561,2506407385955986887998958348924344432211919191723242319161814171313161602500
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
66
0
0
0
0
0
0
0
0000000660000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
258
229
270
326
375
370
366
361
356
351
347
342
337
332
327
323
318
312
308
303
299
294
289
289
279
27928928929429930330831231832332733233734234735135636136637037532627022925800000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
28
27
27
28
27
0
19
17
23
59
62
54
54
155
134
129
120
116
112
0
-1
101
20
42
42
42
110
0
1,480
582
0
0
0
0
00005821,480011042424220101-10112116120129134155545462592317190272827272800000000000
> Total Liabilities 
0
0
3,018
0
883
837
1,225
6,764
5,692
2,717
2,470
2,758
3,221
3,383
2,959
3,565
4,269
4,224
3,965
821
525
720
1,198
1,236
1,882
1,589
2,341
1,786
3,695
4,982
5,109
3,953
3,405
2,993
2,954
3,027
2,508
3,076
3,713
3,182
3,614
4,104
4,685
4,685
2,991
2,9914,6854,6854,1043,6143,1823,7133,0762,5083,0272,9542,9933,4053,9535,1094,9823,6951,7862,3411,5891,8821,2361,1987205258213,9654,2244,2693,5652,9593,3833,2212,7582,4702,7175,6926,7641,22583788303,01800
   > Total Current Liabilities 
0
0
3,018
0
883
837
1,225
6,764
5,692
2,717
2,470
2,758
3,221
3,383
2,959
3,565
4,269
4,224
3,965
821
525
720
1,198
1,009
1,414
1,213
2,030
1,584
3,607
4,960
5,108
3,896
3,383
2,571
2,576
2,709
1,899
2,540
3,261
2,814
3,332
3,911
4,582
4,582
2,976
2,9764,5824,5823,9113,3322,8143,2612,5401,8992,7092,5762,5713,3833,8965,1084,9603,6071,5842,0301,2131,4141,0091,1987205258213,9654,2244,2693,5652,9593,3833,2212,7582,4702,7175,6926,7641,22583788303,01800
       Short-term Debt 
0
0
31
0
1
0
0
4,097
4,057
1,816
1,621
1,879
2,325
2,324
1,937
2,302
2,365
2,241
2,358
0
0
0
0
159
352
365
412
424
435
396
313
330
247
291
283
252
341
346
313
321
330
339
0
349
0
0349033933032131334634125228329124733031339643542441236535215900002,3582,2412,3652,3021,9372,3242,3251,8791,6211,8164,0574,09700103100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
289
298
279
285
686
0
0
0
0
159
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000159000068628527929828900000000000000
       Accounts payable 
0
0
0
0
552
443
226
646
133
681
-333
595
588
768
150
966
1,625
1,699
1,340
821
525
1,458
1,738
597
1,062
0
346
0
0
4
30
3,534
3,027
2,169
1
2
1
2
3
33
15
0
0
4,821
0
04,821001533321212,1693,0273,5343040034601,0625971,7381,4585258211,3401,6991,625966150768588595-3336811336462264435520000
       Other Current Liabilities 
0
0
2,987
0
883
837
999
6,118
5,560
2,717
2,804
2,758
3,221
3,383
2,810
3,565
4,269
4,224
3,965
821
525
720
1,198
850
1,062
848
1,617
1,161
3,171
4,564
4,795
0
3,104
2,248
2,261
2,428
1,537
2,181
2,940
2,452
3,002
3,568
0
4,217
0
04,21703,5683,0022,4522,9402,1811,5372,4282,2612,2483,10404,7954,5643,1711,1611,6178481,0628501,1987205258213,9654,2244,2693,5652,8103,3833,2212,7582,8042,7175,5606,11899983788302,98700
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
30
115
575
475
475
227
468
375
311
201
89
22
1
57
22
422
378
318
609
536
452
368
282
193
103
103
15
1510310319328236845253660931837842222571228920131137546822747547557511530000000000000000000
       Warrants
0
0
0
0
2,766
2,781
2,711
2,461
2,058
1,858
1,471
1,396
1,090
1,090
1,070
1,070
1,005
985
985
965
575
475
475
475
215
0
215
205
0
105
105
105
105
105
0
0
0
0
0
105
105
0
0
0
0
000010510500000105105105105105020521502154754754755759659859851,0051,0701,0701,0901,0901,3961,4711,8582,0582,4612,7112,7812,7660000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
126
13
5
0
0
0
0
0
0
0
0
0
0
0000000000513126290000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29
21
13
0
0
0
0
0
0
0
0
0
0
0
000000000001321290000000000000000000000000000000
> Total Stockholder Equity
0
0
-2,665
0
-778
-426
-872
-4,507
-4,301
-2,140
-1,440
-2,566
-2,328
-3,048
-1,717
-2,109
-3,169
-3,801
-2,265
375
3,653
7,027
3,799
10,668
10,180
12,227
11,362
15,448
33,323
28,651
24,475
19,981
14,248
18,242
12,346
9,499
6,962
1,927
418
2,081
347
-1,055
-2,913
-2,913
99
99-2,913-2,913-1,0553472,0814181,9276,9629,49912,34618,24214,24819,98124,47528,65133,32315,44811,36212,22710,18010,6683,7997,0273,653375-2,265-3,801-3,169-2,109-1,717-3,048-2,328-2,566-1,440-2,140-4,301-4,507-872-426-7780-2,66500
   Common Stock
0
0
8
0
10
11
11
13
15
15
17
17
20
21
23
24
26
26
29
30
37
16
17
20
21
22
23
26
29
30
31
32
32
35
36
39
45
46
55
67
73
79
0
9
0
09079736755464539363532323130292623222120171637302926262423212017171515131111100800
   Retained Earnings Total Equity0000-234,399-223,30600000-180,278-173,025-165,324-157,005-146,7120-116,122-104,7870-84,551-76,601-70,732-65,035-61,884-56,118-56,525-51,981-50,180-47,102-43,829-42,454-40,917-34,825-32,242-30,217-30,595-25,833-22,780-20,102-16,0790000
   Accumulated Other Comprehensive Income 0-1050-105-10500000000-6390-803-680-561-446-88-81-99-94-90-87-84-81-79-76-74-71-68-65-63-60-58-55-53-50-46-420-3400
   Capital Surplus 
0
0
0
0
12,525
16,884
19,186
18,852
24,221
26,204
29,314
30,845
37,479
38,295
41,019
43,898
45,740
46,888
53,216
55,381
64,925
71,571
74,039
86,466
94,495
101,484
115,910
131,340
0
175,228
181,344
185,168
187,136
198,380
0
0
0
0
0
225,215
234,568
0
0
0
0
0000234,568225,21500000198,380187,136185,168181,344175,2280131,340115,910101,48494,49586,46674,03971,57164,92555,38153,21646,88845,74043,89841,01938,29537,47930,84529,31426,20424,22118,85219,18616,88412,5250000
   Treasury Stock000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
9,070
0
12,567
16,930
19,236
18,905
24,276
26,262
29,375
30,908
37,544
38,363
41,090
43,972
46,056
47,247
53,327
55,581
65,012
71,662
74,133
86,874
94,576
102,072
116,356
131,901
169,180
176,031
181,344
185,807
187,136
198,380
201,127
206,240
209,456
210,792
216,232
225,215
234,673
237,832
0
241,988
0
0241,9880237,832234,673225,215216,232210,792209,456206,240201,127198,380187,136185,807181,344176,031169,180131,901116,356102,07294,57686,87474,13371,66265,01255,58153,32747,24746,05643,97241,09038,36337,54430,90829,37526,26224,27618,90519,23616,93012,56709,07000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue18
Cost of Revenue-361
Gross Profit-343-343
 
Operating Income (+$)
Gross Profit-343
Operating Expense-28,530
Operating Income-28,512-28,873
 
Operating Expense (+$)
Research Development5,092
Selling General Administrative23,077
Selling And Marketing Expenses0
Operating Expense28,53028,169
 
Net Interest Income (+$)
Interest Income9
Interest Expense-0
Other Finance Cost-0
Net Interest Income9
 
Pretax Income (+$)
Operating Income-28,512
Net Interest Income9
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-28,690-28,325
EBIT - interestExpense = -28,512
-28,681
-29,041
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-28,512-28,690
Earnings Before Interest and Taxes (EBITDA)-28,151
 
After tax Income (+$)
Income Before Tax-28,690
Tax Provision-0
Net Income From Continuing Ops-28,690-28,690
Net Income-29,041
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses28,530
Total Other Income/Expenses Net-187-9
 

Technical Analysis of Biosig
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosig. The general trend of Biosig is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosig's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of BioSig Technologies, Inc. Common Stock.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 2.44 < 2.554 < 2.57.

The bearish price targets are: 1.26 > 0.52 > 0.45.

Tweet this
BioSig Technologies, Inc. Common Stock Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of BioSig Technologies, Inc. Common Stock. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

BioSig Technologies, Inc. Common Stock Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of BioSig Technologies, Inc. Common Stock. The current macd is 0.36537183.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biosig price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biosig. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biosig price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
BioSig Technologies, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) ChartBioSig Technologies, Inc. Common Stock Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of BioSig Technologies, Inc. Common Stock. The current adx is 60.31.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biosig shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
BioSig Technologies, Inc. Common Stock Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of BioSig Technologies, Inc. Common Stock. The current sar is 2.28.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
BioSig Technologies, Inc. Common Stock Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of BioSig Technologies, Inc. Common Stock. The current rsi is 61.73. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
BioSig Technologies, Inc. Common Stock Daily Relative Strength Index (RSI) ChartBioSig Technologies, Inc. Common Stock Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of BioSig Technologies, Inc. Common Stock. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosig price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
BioSig Technologies, Inc. Common Stock Daily Stochastic Oscillator ChartBioSig Technologies, Inc. Common Stock Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of BioSig Technologies, Inc. Common Stock. The current cci is 52.81.

BioSig Technologies, Inc. Common Stock Daily Commodity Channel Index (CCI) ChartBioSig Technologies, Inc. Common Stock Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of BioSig Technologies, Inc. Common Stock. The current cmo is 14.04.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
BioSig Technologies, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) ChartBioSig Technologies, Inc. Common Stock Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of BioSig Technologies, Inc. Common Stock. The current willr is -46.93576505.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biosig is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
BioSig Technologies, Inc. Common Stock Daily Williams %R ChartBioSig Technologies, Inc. Common Stock Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of BioSig Technologies, Inc. Common Stock.

BioSig Technologies, Inc. Common Stock Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of BioSig Technologies, Inc. Common Stock. The current atr is 0.22435376.

BioSig Technologies, Inc. Common Stock Daily Average True Range (ATR) ChartBioSig Technologies, Inc. Common Stock Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of BioSig Technologies, Inc. Common Stock. The current obv is 53,646,284.

BioSig Technologies, Inc. Common Stock Daily On-Balance Volume (OBV) ChartBioSig Technologies, Inc. Common Stock Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of BioSig Technologies, Inc. Common Stock. The current mfi is 79.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
BioSig Technologies, Inc. Common Stock Daily Money Flow Index (MFI) ChartBioSig Technologies, Inc. Common Stock Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for BioSig Technologies, Inc. Common Stock.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-02MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-09RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-28STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-30WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-11BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

BioSig Technologies, Inc. Common Stock Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of BioSig Technologies, Inc. Common Stock based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5061.728
Ma 20Greater thanMa 501.204
Ma 50Greater thanMa 1000.691
Ma 100Greater thanMa 2000.557
OpenGreater thanClose1.710
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biosig with someone you think should read this too:
  • Are you bullish or bearish on Biosig? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosig? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about BioSig Technologies, Inc. Common Stock

I send you an email if I find something interesting about BioSig Technologies, Inc. Common Stock.


Comments

How you think about this?

Leave a comment

Stay informed about BioSig Technologies, Inc. Common Stock.

Receive notifications about BioSig Technologies, Inc. Common Stock in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.